vândut de liki24.co.uk
Jonexa UP Description A biocompatible hydrogel of cross-linked sodium hyaluronate, obtained by biofermentation and highly purified, dissolved in a physiological and isotonic buffer. The product is an injectable, sterile and pyrogen-free hydrogel with low levels of endotoxins. JONEXA UP is formulated with highly purified sodium hyaluronate, quality salts compliant with the requirements reported in the Pharmacopoeia and water for injections. JONEXA UP reduces pain and increases the functionality of the affected joint. JONEXA UP provides a lubricating and shock-absorbing effect on the affected joint. JONEXA UP improves the patients quality of life. JONEXA UP should be administered by intra-articular injection by a qualified physician, following all rules regarding aseptic procedure and injection technique. JONEXA UP should be injected with an appropriate sterile needle (18-21G needles are recommended). It is recommended to administer JONEXA UP in a single session. The amount of product administered is at the discretion of the physician. Discard any unused portion of the syringe. How to use JONEXA UP should be injected into the joint in the synovial space of the knee, as a means of viscosupplementing synovial fluid, when the viscosity of the fluid is reduced due to the osteoarthritis process, in patients who have not responded adequately to conservative non-pharmacological therapy and simple analgesics. 1. Before injection, the area to be treated must be thoroughly disinfected and the product must be brought to room temperature. 2. Open the sterile packaging and remove the syringe from inside. 3. Remove the cap from the tip of the syringe without touching it, to keep it sterile. 4. Attach a suitable sterile needle (18-21G needles are recommended) to the tip of the syringe. Check that the needle is properly attached to the syringe Luer-lock adapter before use. 5. Remove air from the syringe, if necessary. 6. Inject into the joint in the synovial space of the affected knee, following aseptic injection procedures. 7. At the end of the treatment session, discard the syringe and any remaining product. The amount of product to be administered is at the discretion of the specialist, the recommended dose being 3-4 ml for each knee joint. components Cross-linked sodium hyaluronate 20 mg/ml, disodium phosphate dodecahydrate 0.6 mg/ml, disodium phosphate dihydrate 0.05 mg/ml, sodium chloride 8 mg/ml, water for injections qb warnings Do not administer JONEXA UP to patients with known hypersensitivity (allergy) to hyaluronic acid and/or other components of the product. Do not administer JONEXA UP to patients with acute or chronic dermatological conditions or inflammatory and/or infectious skin problems. Do not administer JONEXA UP to patients with coagulation disorders and/or who are receiving treatment with anticoagulant drugs. JONEXA UP should not be administered to pregnant or breastfeeding women. JONEXA UP should not be administered to children. The use of JONEXA UP in any joint other than the knee and for other conditions has not been studied. JONEXA UP should be injected strictly into the intraarticular space, following aseptic injection procedures. JONEXA UP should be administered with sterile Luer-lock needles. Do not inject into a blood vessel or surrounding tissue. To avoid pain after injection, it is recommended to keep the injection site still. The product should not be used if the packaging is damaged or broken. The product should not be used after the expiration date. The product is for single use only. Do not reuse; risk of infection. Do not resterilize, resterilization may affect the physicochemical properties of the product and compromise its efficacy and safety. The used syringe and needle should be discarded in an appropriate container. Keep out of reach of children. Do not use with other products containing quaternary ammonium salts, such as benzalkonium chloride, or with any surgical material treated with these substances, as sodium hyaluronate may precipitate in their presence. To prevent any possible interactions, avoid concomitant administration with other intra-articular products. There are no known interactions with other local anesthetics. Conservation Store between 5°C and 25°C. Protect from light and avoid freezing. Do not use after the expiry date stated on the packaging. Format 4.4 ml syringe. Code 6801
Preț:
Vânzător: Liki24.co.uk
Brand: N/a
